Pathogenic Viruses Commonly Present in the Oral Cavity and Relevant Antiviral Compounds Derived from Natural Products.
Daisuke AsaiHideki NakashimaPublished in: Medicines (Basel, Switzerland) (2018)
Many viruses, such as human herpesviruses, may be present in the human oral cavity, but most are usually asymptomatic. However, if individuals become immunocompromised by age, illness, or as a side effect of therapy, these dormant viruses can be activated and produce a variety of pathological changes in the oral mucosa. Unfortunately, available treatments for viral infectious diseases are limited, because (1) there are diseases for which no treatment is available; (2) drug-resistant strains of virus may appear; (3) incomplete eradication of virus may lead to recurrence. Rational design strategies are widely used to optimize the potency and selectivity of drug candidates, but discovery of leads for new antiviral agents, especially leads with novel structures, still relies mostly on large-scale screening programs, and many hits are found among natural products, such as extracts of marine sponges, sea algae, plants, and arthropods. Here, we review representative viruses found in the human oral cavity and their effects, together with relevant antiviral compounds derived from natural products. We also highlight some recent emerging pharmaceutical technologies with potential to deliver antivirals more effectively for disease prevention and therapy.
Keyphrases
- drug resistant
- endothelial cells
- induced pluripotent stem cells
- infectious diseases
- escherichia coli
- public health
- emergency department
- stem cells
- intensive care unit
- high throughput
- sars cov
- cross sectional
- helicobacter pylori
- mass spectrometry
- small molecule
- cystic fibrosis
- mesenchymal stem cells
- bone marrow
- climate change
- electronic health record
- smoking cessation
- free survival